title: Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose".
authors.affiliation: a University of Leuven , Leuven , Belgium.
authors.forename: Marijke
authors.initials: M
authors.lastname: Peetermans
authors.affiliation: a University of Leuven , Leuven , Belgium.
authors.forename: Peter
authors.initials: P
authors.lastname: Verhamme
mesh_terms: D000991:Antithrombins / Q000627:therapeutic use*; D000069604:Dabigatran; D062787:Drug Overdose / Q000188:drug therapy; D006801:Humans
chemical_list: D000991:Antithrombins; D000069604:Dabigatran